Efficacy and safety of oral gemifloxacin for the empirical treatment of pneumonia.

about

Clarithromycin versus Gemifloxacin in Quadruple Therapeutic Regimens for Helicobacter Pylori Infection Eradication.The impact of policy guidelines on hospital antibiotic use over a decade: a segmented time series analysis

P2860

Q33798957-9F28E63F-DB31-4452-8296-23098A1B541A Q35125122-FD615DFF-434B-4938-BECB-DF61E5B80F2F

P2860

Efficacy and safety of oral gemifloxacin for the empirical treatment of pneumonia.

Item

http://www.wikidata.org/entity/Q36181003

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

Efficacy and safety of oral gemifloxacin for the empirical treatment of pneumonia.

@ast

Efficacy and safety of oral gemifloxacin for the empirical treatment of pneumonia.

@en

type

Item

label

Efficacy and safety of oral gemifloxacin for the empirical treatment of pneumonia.

@ast

Efficacy and safety of oral gemifloxacin for the empirical treatment of pneumonia.

@en

prefLabel

Efficacy and safety of oral gemifloxacin for the empirical treatment of pneumonia.

@ast

Efficacy and safety of oral gemifloxacin for the empirical treatment of pneumonia.

@en

P1476

Efficacy and safety of oral gemifloxacin for the empirical treatment of pneumonia.

@en

P2093

Anish Singhal

http://www.w3.org/2001/XMLSchema#string

Narmada Patel

http://www.w3.org/2001/XMLSchema#string

Pankaj Mishra

http://www.w3.org/2001/XMLSchema#string

Sudhir Kumar

http://www.w3.org/2001/XMLSchema#string

Vindu Amitabh

http://www.w3.org/2001/XMLSchema#string

Yasir S Rizvi

http://www.w3.org/2001/XMLSchema#string

P2860

Infectious Diseases Society of America/American Thoracic Society Consensus Guidelines on the Management of Community-Acquired Pneumonia in Adults

Study of community acquired pneumonia aetiology (SCAPA) in adults admitted to hospital: implications for management guidelines

Guidelines for the management of adults with community-acquired pneumonia. Diagnosis, assessment of severity, antimicrobial therapy, and prevention

Quinolone generations: natural history or natural selection?

The impact of penicillin resistance on short-term mortality in hospitalized adults with pneumococcal pneumonia: a systematic review and meta-analysis.

Gemifloxacin for the treatment of respiratory tract infections: in vitro susceptibility, pharmacokinetics and pharmacodynamics, clinical efficacy, and safety.

Gemifloxacin once daily for 5 days versus 7 days for the treatment of community-acquired pneumonia: a randomized, multicentre, double-blind study.

Gemifloxacin: a new fluoroquinolone approved for treatment of respiratory infections.

Therapeutic options for pneumococcal pneumonia in Turkey.

Penicillin-resistant pneumococci.

P304

248-253

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4103/0970-2113.99109

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2012-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22919164

http://www.w3.org/2001/XMLSchema#string

P932

3424864

http://www.w3.org/2001/XMLSchema#string

Efficacy and safety of oral gemifloxacin for the empirical treatment of pneumonia.

about

P2860

P2860

Efficacy and safety of oral gemifloxacin for the empirical treatment of pneumonia.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P932